TMS Insurance Coverage in Maine: Preparing for Approval

TMS Insurance Coverage in Maine: Preparing for Approval

Transcranial magnetic stimulation (TMS) is a non-invasive treatment commonly considered for adults with major depressive disorder when other treatments have not brought enough improvement. It uses magnetic pulses delivered to areas of the brain involved in mood regulation. A standard treatment course often involves weekday appointments over several weeks, so it is sensible to check insurance arrangements before treatment begins.

In Maine, cover can depend on your individual policy, diagnosis, treatment history and the insurer’s medical-necessity criteria. Insurers commonly seen by TMS providers in the state include Anthem Blue Cross and Blue Shield, Harvard Pilgrim Health Care, Aetna, Cigna, Community Health Options and MaineCare. Having cover through one of these plans does not automatically mean TMS will be approved, but your clinic can usually help you understand what information is needed.

The main task is often showing that TMS is an appropriate next treatment for you, based on a clear record of depression symptoms and previous care.

Why insurers ask for prior authorisation

Many health plans require prior authorisation before they will pay for TMS. This means the insurer reviews clinical information before treatment starts and decides whether the proposed course meets its policy rules.

Prior authorisation is not the same as a clinical recommendation. Your prescribing clinician may believe TMS is suitable, but the insurer will still usually want documentation supporting that decision. The review commonly considers:

• Your diagnosis and current symptoms
• How long symptoms have been present
• Previous antidepressant medication trials
• Whether medication was ineffective, not tolerated or unsuitable
• Previous talking therapy or other mental health treatment
• Standardised symptom ratings
• Your clinician’s treatment plan and reasons for recommending TMS

The exact requirements vary between plans, including different plans offered by the same insurer. A clinic’s administrative team may submit the request, but you may need to provide records or contact previous prescribers to help complete the evidence.

It is worth asking your insurer whether authorisation is needed for both the initial treatment course and any treatment that may be requested later. Ask what your expected out-of-pocket costs could be, including deductibles, co-payments and coinsurance.

Medication trials: what documentation may be needed

Insurers often look for evidence that depression has not improved sufficiently after appropriate treatment with antidepressant medication. This is sometimes described as treatment-resistant depression, although insurers and clinicians may define this differently.

A useful medication record normally includes:

• The name of each medication
• The dose or dose range used
• Approximate start and stop dates
• How long you took it
• Whether the dose was adjusted
• The effect on your symptoms
• Any side effects or medical reasons it could not be continued
• The reason it was stopped or changed

Try not to rely on memory alone, particularly if you have tried medicines over several years. Your GP, psychiatrist, mental health prescriber or pharmacy may be able to provide records. If a medication was stopped because of difficult side effects, make sure this is recorded clearly. “Did not tolerate” is more helpful to an insurer when it is accompanied by a brief clinical explanation.

Do not restart, stop or alter medication simply to meet an insurance requirement. Treatment decisions should be made with the clinician who prescribes your medicine.

Some plans may also consider whether you have received medication at an adequate dose and for an adequate length of time. What counts as adequate depends on the medicine, your health circumstances and the plan’s policy. Your treating clinician can explain why a trial was appropriate in your case, including when a usual dose or duration was not safe or tolerable.

Therapy and other treatment history

Many insurers also ask about psychotherapy, often called counselling or talking therapy. They may want to know whether you have tried therapy, are currently in therapy, or whether therapy was recommended but not accessible or appropriate at a particular time.

Records may include:

• The type of therapy received, if known
• Approximate dates of sessions or treatment periods
• The name of the clinician or service
• Whether therapy was ongoing alongside medication
• Progress notes or a treatment summary where available
• Reasons therapy was ended, paused or not possible

You do not need to produce deeply personal therapy notes yourself. A brief treatment summary from a therapist or mental health service is often more appropriate. It can confirm attendance, general treatment goals and whether symptoms continued despite care, without sharing details that are not necessary for an insurance review.

If you have received treatment through different practices, ask early for records. Administrative requests can take time, and a missing summary may delay the authorisation process.

Symptom scores and clinical assessment

TMS authorisation requests commonly include standardised depression questionnaires. These tools help clinicians track symptom severity before, during and after treatment. They do not replace a full clinical assessment, but they can provide a consistent record of how depression affects you over time.

Your clinic may ask you to complete a questionnaire at the first assessment and at intervals during treatment. It is important to answer as accurately as you can, based on how you have been feeling during the period the questionnaire asks about.

Your clinician may also document symptoms such as:

• Persistent low mood or loss of interest
• Changes in sleep, appetite or energy
• Difficulty concentrating
• Slowed thinking or movement, or agitation
• Feelings of hopelessness, guilt or worthlessness
• The impact of symptoms on work, study, relationships or daily tasks

If you have anxiety alongside depression, tell your clinician. TMS received FDA clearance for major depressive disorder in 2008 and for depression with comorbid anxiety in 2021. Insurance decisions still depend on the wording of your own plan and the medical information submitted.

How the prior authorisation process usually works

The process often begins with an assessment at a TMS clinic or with the clinician referring you. They will review your diagnosis, treatment history, medicines and current symptoms. If TMS appears suitable, the clinic may ask you to sign forms allowing it to request records and speak with your insurer.

The clinic then prepares a prior authorisation request. This may include the clinician’s assessment, medication history, relevant therapy information, symptom scores and a proposed treatment schedule. A typical TMS course is around 36 weekday sessions over roughly six to nine weeks, though the plan recommended for you may differ.

After submission, the insurer may approve the request, ask for more information or decline it. A request for further information does not necessarily mean the treatment has been rejected. It may mean a medication date, dose, diagnosis detail or supporting record is missing.

Before arranging regular sessions, ask the clinic:

• Has authorisation been submitted?
• Has approval been confirmed in writing?
• Which parts of treatment are included in the approval?
• Is there an expiry date or a limit on authorised sessions?
• What will I be asked to pay?
• Who will contact the insurer if more records are needed?

Keep copies of messages, letters, reference numbers and any explanation of benefits you receive. If a claim or authorisation issue arises later, this record can be useful.

Gathering records without becoming overwhelmed

Start with a simple timeline. Write down the clinicians, practices and pharmacies involved in your depression care, beginning with the most recent. Include approximate dates if exact dates are unavailable.

You might create a folder, paper or digital, containing:

• A current list of medicines and doses
• Previous medication lists
• Contact details for prescribers and therapists
• Therapy summaries, if available
• Previous psychiatric assessments or discharge summaries
• Recent symptom questionnaire results
• Your insurance card and member details
• Any letters about authorisation or benefits

If you cannot obtain every older record, tell the TMS clinic. A current prescriber may be able to prepare a treatment summary from available notes and your history. Be honest about uncertainty rather than guessing dates or doses.

It may also help to ask a trusted relative, friend or carer to assist with collecting paperwork, especially if depression is making administrative tasks feel difficult. They can help organise documents, make a list of questions or sit with you during insurer calls, with your permission.

If approval is delayed or declined

A delay or refusal can be discouraging, but it may be possible to request a review or appeal. First, ask for the reason in writing. Common issues can include missing documentation, a mismatch between the submitted diagnosis and the plan’s criteria, or incomplete details of medication trials.

Your clinic may be able to submit additional information or request a peer-to-peer review, where the treating clinician discusses the case with a clinician working for the insurer. If an appeal is available, follow the instructions and deadlines in the insurer’s decision letter.

You can also ask whether the plan has a separate process for exceptions or external review. The appropriate route depends on your policy and the reason for the decision.

Getting help in Maine

TMS Therapy Maine lists 16 published clinics across the state, including options in South Portland, Scarborough, Camden, Portland, York, Brunswick, Brewer, Falmouth and Waterville. Use the directory’s clinic listings to identify local services, read the insurance guide for practical cover questions, or visit the contact page for help using the directory.

This information is educational only and is not medical advice.